177Lu-dotatate use in chronic kidney disease patients: A single center experience:

Sandhya Manohar,Panagiotis Kompotiatis,Thorvardur R. Halfdanarson,Timothy J. Hobday,Matthew P. Thorpe,Geoffrey B. Johnson,Ayse Tuba Kendi,Nelson Leung

177Lu-dotatate use in chronic kidney disease patients: A single center experience:

2021

Sandhya Manohar
Panagiotis Kompotiatis
Thorvardur R. Halfdanarson
Timothy J. Hobday
Matthew P. Thorpe
Geoffrey B. Johnson
Ayse Tuba Kendi
Nelson Leung

Background:Peptide receptor radionuclide therapy with 177Lu-dotatate is a novel therapy for metastatic neuroendocrine cancers. It undergoes reabsorption at the proximal tubule; after the breakdown ...

Keywords:

Acute kidney injury
Single Center
peptide receptor
177Lu-DOTATATE
Reabsorption
radionuclide therapy
Urology
Medicine
Kidney disease
Proximal tubule

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations